These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 12377741)
1. Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Papafili A; Hill MR; Brull DJ; McAnulty RJ; Marshall RP; Humphries SE; Laurent GJ Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1631-6. PubMed ID: 12377741 [TBL] [Abstract][Full Text] [Related]
2. A functional polymorphism in the promoter region of the cyclooxygenase-2 gene is not associated with asthma and atopy in an Australian population. Shi J; Misso NL; Duffy DL; Thompson PJ; Kedda MA Clin Exp Allergy; 2004 Nov; 34(11):1714-8. PubMed ID: 15544595 [TBL] [Abstract][Full Text] [Related]
3. A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. Cipollone F; Toniato E; Martinotti S; Fazia M; Iezzi A; Cuccurullo C; Pini B; Ursi S; Vitullo G; Averna M; Arca M; Montali A; Campagna F; Ucchino S; Spigonardo F; Taddei S; Virdis A; Ciabattoni G; Notarbartolo A; Cuccurullo F; Mezzetti A; JAMA; 2004 May; 291(18):2221-8. PubMed ID: 15138244 [TBL] [Abstract][Full Text] [Related]
4. Association of a promoter variant in the inducible cyclooxygenase-2 gene (PTGS2) with type 2 diabetes mellitus in Pima Indians. Konheim YL; Wolford JK Hum Genet; 2003 Oct; 113(5):377-81. PubMed ID: 12920574 [TBL] [Abstract][Full Text] [Related]
5. Functional promoter polymorphism of cyclooxygenase-2 modulates the inflammatory response in stable coronary heart disease. Sanak M; Plutecka H; Szczeklik W; Piwowarska W; Rostoff P; Szczeklik A Pol Arch Med Wewn; 2010 Mar; 120(3):82-8. PubMed ID: 20332714 [TBL] [Abstract][Full Text] [Related]
6. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism. Brosens LA; Iacobuzio-Donahue CA; Keller JJ; Hustinx SR; Carvalho R; Morsink FH; Hylind LM; Offerhaus GJ; Giardiello FM; Goggins M Clin Cancer Res; 2005 Jun; 11(11):4090-6. PubMed ID: 15930344 [TBL] [Abstract][Full Text] [Related]
7. Role of COX-2 activity and CRP levels in patients with non-melanoma skin cancer. -765G>C PTGS2 polymorphism and NMSC risk. Cocoş R; Schipor S; Nicolae I; Thomescu C; Raicu F Arch Dermatol Res; 2012 Jul; 304(5):335-42. PubMed ID: 22159575 [TBL] [Abstract][Full Text] [Related]
8. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. Szczeklik W; Sanak M; Szczeklik A J Allergy Clin Immunol; 2004 Aug; 114(2):248-53. PubMed ID: 15316498 [TBL] [Abstract][Full Text] [Related]
9. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs. Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339 [TBL] [Abstract][Full Text] [Related]
10. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Zhang X; Miao X; Tan W; Ning B; Liu Z; Hong Y; Song W; Guo Y; Zhang X; Shen Y; Qiang B; Kadlubar FF; Lin D Gastroenterology; 2005 Aug; 129(2):565-76. PubMed ID: 16083713 [TBL] [Abstract][Full Text] [Related]
11. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism. Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453 [TBL] [Abstract][Full Text] [Related]
12. Genotypic effect of the -565C>T polymorphism in the ABCA1 gene promoter on ABCA1 expression and severity of atherosclerosis. Kyriakou T; Hodgkinson C; Pontefract DE; Iyengar S; Howell WM; Wong YK; Eriksson P; Ye S Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):418-23. PubMed ID: 15528481 [TBL] [Abstract][Full Text] [Related]
13. Functional rs20417 SNP (-765G>C) of cyclooxygenase-2 gene does not predict the risk of recurrence of ischemic events in coronary patients: results of a 7-year prospective study. Montali A; Barillà F; Tanzilli G; Vestri A; Fraioli A; Gaudio C; Martino F; Mezzetti A; Cipollone F; Arca M Cardiology; 2010; 115(3):236-42. PubMed ID: 20299798 [TBL] [Abstract][Full Text] [Related]
14. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation. Lira MG; Mazzola S; Tessari G; Malerba G; Ortombina M; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Girolomoni G; Turco A Br J Dermatol; 2007 Jul; 157(1):49-57. PubMed ID: 17578436 [TBL] [Abstract][Full Text] [Related]
15. [Association of common cyclooxygenase-2 (COX-2) gene polymorphisms with clinical and angiographic characteristics of patients with coronary artery disease]. Rostoff P; Szczeklik W; Piwowarska W; Konduracka E; Sanak M; Nessler J Przegl Lek; 2014; 71(6):314-8. PubMed ID: 25344971 [TBL] [Abstract][Full Text] [Related]
16. Promoter methylation regulates cyclooxygenase expression in breast cancer. Ma X; Yang Q; Wilson KT; Kundu N; Meltzer SJ; Fulton AM Breast Cancer Res; 2004; 6(4):R316-21. PubMed ID: 15217498 [TBL] [Abstract][Full Text] [Related]
17. Fibronectin stimulates human lung carcinoma cell growth by inducing cyclooxygenase-2 (COX-2) expression. Han S; Sidell N; Roser-Page S; Roman J Int J Cancer; 2004 Sep; 111(3):322-31. PubMed ID: 15221958 [TBL] [Abstract][Full Text] [Related]
18. Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia. Suk Danik J; Chasman DI; Cannon CP; Miller DT; Zee RY; Kozlowski P; Kwiatkowski DJ; Ridker PM Ann Hum Genet; 2006 Nov; 70(Pt 6):705-16. PubMed ID: 17044845 [TBL] [Abstract][Full Text] [Related]
19. Interaction of cyclooxygenase-2 variants and smoking in pancreatic cancer: a possible role of nucleophosmin. Zhao D; Xu D; Zhang X; Wang L; Tan W; Guo Y; Yu D; Li H; Zhao P; Lin D Gastroenterology; 2009 May; 136(5):1659-68. PubMed ID: 19422084 [TBL] [Abstract][Full Text] [Related]
20. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells. Han S; Inoue H; Flowers LC; Sidell N Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]